Form 4 holding
Director
ILLUMINA, INC.
- Security class
- Common Stock
- Shares / value
- 148,933
- Estimated value
- $16,900,902
- Report date
- 18 May 2021
- Price
- $113.48
- Ownership
- Direct
Flatley Jay T.
Insider Reports History
- Reporting-owner location
- San Diego, CA
- Latest reporting-owner signature
- /s/ Tyler Nielsen, by power of attorney
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Flatley Jay T.
Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 336,313
- Estimated value
- $6,457,209
- Report date
- 03 Jun 2026
- Price
- $19.20
- Ownership
- Indirect
Form 4 holding
Director
Rivian Automotive, Inc. / DE
- Security class
- Class A Common Stock
- Shares / value
- 162,070
- Estimated value
- $1,433,347
- Report date
- 17 Apr 2024
- Price
- $8.84
- Ownership
- Direct
Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 22,628
- Estimated value
- $434,457
- Report date
- 03 Jun 2026
- Price
- $19.20
- Ownership
- Direct
Form 4 holding
Director
ILLUMINA, INC.
- Security class
- Common Stock
- Shares / value
- 3,500
- Estimated value
- $397,180
- Report date
- 18 May 2021
- Price
- $113.48
- Ownership
- By Daughters
Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 19,226
- Estimated value
- Report date
- 03 Jun 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Dynamics Special Purpose Corp.
- Security class
- Class A common stock
- Shares / value
- 10,733
- Estimated value
- Report date
- 25 May 2021
- Price
- Ownership
- Indirect
Form 4 holding
Director
COHERENT INC
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jul 2022
- Price
- $263.44
- Ownership
- By Family Trust
Form 4 holding
Chairman and Acting CEO, Director
Zymergen Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- Report date
- 19 Oct 2022
- Price
- $2.80
- Ownership
- Direct
Form 4 holding
Chairman and Acting CEO, Director
Zymergen Inc.
- Security class
- Stock Options
- Shares / value
- 0
- Estimated value
- Report date
- 19 Oct 2022
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Flatley Jay T.
4
DNLI
Denali Therapeutics Inc.
- Report period
- 03 Jun 2026
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 05 Jun 2026, 16:46
- Role
- Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 18 Jun 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 20 Jun 2025, 17:16
- Role
- Director
- Next action
- Open filing details
4
DNLI
Denali Therapeutics Inc.
- Report period
- 03 Jun 2025
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 05 Jun 2025, 16:33
- Role
- Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 18 Jun 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 21 Jun 2024, 16:52
- Role
- Director
- Next action
- Open filing details
4
DNLI
Denali Therapeutics Inc.
- Report period
- 31 May 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 04 Jun 2024, 18:28
- Role
- Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 21 Jun 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 23 Jun 2023, 19:00
- Role
- Director
- Next action
- Open filing details
4
DNLI
Denali Therapeutics Inc.
- Report period
- 01 Jun 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 05 Jun 2023, 18:03
- Role
- Director
- Next action
- Open filing details
4
Zymergen Inc.
- Report period
- 19 Oct 2022
- Transactions
- 3
- Transaction value
- $0
- Accepted by SEC
- 19 Oct 2022, 20:17
- Role
- Chairman and Acting CEO, Director
- Next action
- Open filing details
4
COHR
COHERENT INC
- Report period
- 01 Jul 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 01 Jul 2022, 16:32
- Role
- Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 06 Jun 2022
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 08 Jun 2022, 17:35
- Role
- Director
- Next action
- Open filing details
4
DNLI
Denali Therapeutics Inc.
- Report period
- 02 Jun 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 06 Jun 2022, 20:07
- Role
- Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 26 May 2022
- Transactions
- 1
- Transaction value
- +$1,172,400
- Accepted by SEC
- 31 May 2022, 17:36
- Role
- Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 11 Jan 2022
- Transactions
- 8
- Transaction value
- +$13,506
- Accepted by SEC
- 05 Mar 2026, 17:10
- Role
- Director
- Next action
- Open filing details
4
Zymergen Inc.
- Report period
- 17 Nov 2021
- Transactions
- 1
- Transaction value
- +$1,000,000
- Accepted by SEC
- 19 Nov 2021, 15:30
- Role
- Chairman and Acting CEO, Director
- Next action
- Open filing details
4
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 15 Nov 2021
- Transactions
- 1
- Transaction value
- +$1,560,000
- Accepted by SEC
- 17 Nov 2021, 18:47
- Role
- Director
- Next action
- Open filing details
3
RIVN
Rivian Automotive, Inc. / DE
- Report period
- 09 Nov 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 09 Nov 2021, 20:17
- Role
- Director
- Next action
- Open filing details
4
Zymergen Inc.
- Report period
- 06 Aug 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 09 Aug 2021, 20:50
- Role
- Chairman and Acting CEO, Director
- Next action
- Open filing details
4
DNLI
Denali Therapeutics Inc.
- Report period
- 02 Jun 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 04 Jun 2021, 18:33
- Role
- Director
- Next action
- Open filing details
4
DNLI
Denali Therapeutics Inc.
- Report period
- 01 Jun 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 03 Jun 2021, 20:53
- Role
- Director
- Next action
- Open filing details
3
SNTI
Dynamics Special Purpose Corp.
- Report period
- 25 May 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 25 May 2021, 20:23
- Role
- Director
- Next action
- Open filing details
4
ILMN
ILLUMINA, INC.
- Report period
- 18 May 2021
- Transactions
- 1
- Transaction value
- -$1,518,120
- Accepted by SEC
- 20 May 2021, 16:51
- Role
- Director
- Next action
- Open filing details
4
COHR
COHERENT INC
- Report period
- 06 May 2021
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 10 May 2021, 17:09
- Role
- Director
- Next action
- Open filing details